Opening Grand Keynote
Grand Keynote: Innovating in Healthcare - Through The Pandemic and Beyond
When & Where
05/07/2021
7:45 am – 8:30 am
Main Stage
About This Talk
Gilead Chairman and CEO Daniel O’Day joins us to discuss how his company came up with remdesivir, an antiviral medicine that is now being used to treat COVID-19 throughout the world. We’ll also hear how Gilead is continuing the fight against cancer, HIV and other diseases in a fast-changing environment. Moderator, Rich Karlgaard explores the leadership attributes that Daniel applies to his role and discusses the intersection of healthcare and technology
Speakers
Daniel O'Day
Chairman and Chief Executive Officer
Gilead Sciences, Inc.
Gilead Sciences, Inc.
Daniel O'Day joined Gilead Sciences in March 2019 as Chairman of the board of directors and Chief Executive Officer.
Prior to Gilead, Daniel served as the Chief Executive Officer of Roche Pharmaceuticals. His career at Roche spanned more than three decades, during which he held a number of executive positions in the company's pharmaceutical and diagnostics divisions in North America, Europe and Asia. He served as a member of the Roche's Corporate Executive Committee, as well as on a number of public and private boards, including Genentech, Flatiron Health and Foundation Medicine.
Daniel O'Day holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University in New York. He currently serves on the board of directors for the Pharmaceutical Research and Manufacturers of America organization.
Prior to Gilead, Daniel served as the Chief Executive Officer of Roche Pharmaceuticals. His career at Roche spanned more than three decades, during which he held a number of executive positions in the company's pharmaceutical and diagnostics divisions in North America, Europe and Asia. He served as a member of the Roche's Corporate Executive Committee, as well as on a number of public and private boards, including Genentech, Flatiron Health and Foundation Medicine.
Daniel O'Day holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University in New York. He currently serves on the board of directors for the Pharmaceutical Research and Manufacturers of America organization.
Award-winning entrepreneur-turned-publisher, columnist, author, television commentator, private investor and board director, Rich Karlgaard has a unique vantage point on the trends driving the business and economic climates.Karlgaard is the publisher of Forbes magazine and writes a biweekly column, Innovation Rules, known for its witty and honest assessment of current business issues, and serves as a regular panelist on cable news’ most popular business show, Forbes on FOX.